Future Royalties. In the event that the Escrow Technology is ---------------- accessed by ATUGEN as provided in this Section 2.4, ATUGEN will be responsible for all payments which become due to third parties as a result of action taken by ATUGEN in the Field.
Appears in 3 contracts
Sources: License Agreement (Ribozyme Pharmaceuticals Inc), License Agreement (Ribozyme Pharmaceuticals Inc), License Agreement (Ribozyme Pharmaceuticals Inc)